Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study

BACKGROUND: This study aimed to analyze the clinical outcomes associated with patients with recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC) who received cetuximab-based chemotherapy in a real-world clinical setting. METHODS: Clinical data were extracted from RM HNSCC patients d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui-Ching, Liu, Pei-Lin, Lo, Pei-Chuan, Chang, Yi-Tzu, Chan, Leong-Perng, Yeh, Tsung-Jang, Hsiao, Hui-Hua, Cho, Shih-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Drugs and Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487150/
https://www.ncbi.nlm.nih.gov/pubmed/32974098
http://dx.doi.org/10.7717/peerj.9862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487150/
https://www.ncbi.nlm.nih.gov/pubmed/32974098
http://dx.doi.org/10.7717/peerj.9862

Ejemplares similares